Keyphrases
Randomized Double-blind Trial
100%
Laparoscopic Sleeve Gastrectomy
100%
Sleeve Gastrectomy
100%
Probiotic Administration
100%
Quality of Life
66%
Placebo
66%
Non-alcoholic Fatty Liver Disease (NAFLD)
66%
Clinical Outcomes
66%
Body Mass Index
33%
Between-group
33%
Microbial Composition
33%
Randomized Placebo-controlled Trial
33%
Liver Enzymes
33%
Fibrosis
33%
Disease Remission
33%
Liver Fat Content
33%
C-reactive Protein
33%
Fecal Samples
33%
Leptin
33%
Morbid Obesity
33%
Bariatric Surgery
33%
Remission Rate
33%
Fat Content
33%
Microbial Diversity
33%
Shear Wave Elastography
33%
Metabolic Parameters
33%
Abdominal Ultrasound
33%
12-month Follow-up
33%
Cytokeratin 18
33%
Alpha Diversity
33%
Inflammatory Parameters
33%
Placebo Groups
33%
Fibrosis Liver
33%
Medicine and Dentistry
Probiotic Agent
100%
Sleeve Gastrectomy
100%
Placebo
66%
Laparoscopic Sleeve Gastrectomy
50%
Spontaneous Remission
33%
Fibrosis
33%
Nonalcoholic Fatty Liver
33%
Fat Content
33%
Quality of Life
33%
Body Mass Index
16%
Liver Enzyme
16%
Arm
16%
C Reactive Protein
16%
Anthropometry
16%
Keratin 18
16%
Shear Wave Elastography
16%
Bariatric Surgery
16%
Leptin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Probiotic Agent
100%
Placebo
66%
Nonalcoholic Fatty Liver
33%
Remission
33%
Fibrosis
33%
Microflora
16%
Liver Enzyme
16%
Fatty Liver
16%
Cytokeratin 18
16%
C Reactive Protein
16%
Leptin
16%